3Belsey JD.Choice of angiotensin receptor blocker in moderate hypertension. A UK-based cost-benefitcomparison of olmesartan- and eandesartan- based regimens[J].J Med Econ, 2011,14 ( 5 ) : 553-561.
4Murad JP, Espinosa EV, Ting HJ, et al.Characterization of the in vivo antiplatelet activity of the antihypertensive agent losartan[J].J Cardiovase Pharmacol Ther,2012,17 ( 3 ) : 308-314.
5Mancia G, Parodi A, Merlino L, et al.Heterogeneity in antihypertensive treatment discontinuation between drugs belonging to the same class[J].J Hypertens, 2011,29 ( 5 ) : 1012-1018.
6Smith DH.Comparison of angiotensin I[ type 1 receptor antagonists in the treatment of essential hypertension[J].Drugs, 2008,68 ( 9 ): 1207-1225.
7Fuch FD, Fuchs SC, Morelra LB, et al.A comparison between diuretics and angiotensin-receptor blocker agents in patients with stage I hypertension ( PREVER-treatment trial ) : study protocol for a randomized double-blind controlled trial[J].Trials, 201 l, 24 ( 12 ) : 53.
9Ping G, Qian W, Song G, et al. Valsartan reverses depressive/ anxiety - like behavior and induces hippocampal neurogenesis and expression of BDNF protein in unpredictable chronic mild stress mice [J]. Pharmacol Biochem Behav, 2014 (124) : 5 -12.
10de la Sierra A, Roca - Cusachs A, Red6n J, et al. Effectiveness and tolerability of fixed dose combination of ena|april plus nitrendipine in hypertensive patients: results of the 3 - month observational, post - marketing, multieentre, prospective CENIT study [ J]. Clin Drug Investig, 2009, 29 (7): 459-469.
